A Study of Omega-3 as an Augmentor of Antidepressant Treatment for Major Depression
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether augmentation of antidepressant medication
with Omega-3 polyunsaturated fatty acids increases the speed and degree of improvement for
patients with major depression
Phase:
Phase 2
Details
Lead Sponsor:
The University of New South Wales
Collaborators:
Ocean Nutrition Sphere Healthcare Your Health Inc.